Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.

American journal of hematology - 1 Feb 2002

Ito K, Kinjo K, Nakazato T, Ikeda Y, Kizaki M

Abstract excerpt

p33(ING1) is a novel candidate tumor suppressor gene which is involved in the regulation of apoptosis. p33(ING1) interacts with p53 signaling pathway and regulates cellular growth. It has reported that the expression of p33(ING1) mRNA was decreased in lymphoid malignancies. We thus investigated the potential involvement of p33(ING1) abnormalities in myeloid leukemias. However, the levels of p33(ING1) transcript...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colonic Neoplasms
Share to DNA, Neoplasm
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Inhibitors

Share to HL-60 Cells

Share to Leukemia, Myeloid, Acute

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 11835353
DOI: 10.1002/ajh.10031

Genes

ING1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.PMID 11835353Read ↗

The role of the tumour suppressor p33 ING1b in human neoplasia.Semantic proximity Read ↗

Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressorSemantic proximity Read ↗

Downregulation of nuclear expression of the p33 <sup>ING1b</sup> inhibitor of growth protein in invasive carcinoma of the breastSemantic proximity Read ↗

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemiaSemantic proximity Read ↗

[Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma].Semantic proximity Read ↗

[Mutation of ING1 gene in laryngeal squamous cell carcinoma and its association with p33ING1b protein expression].Semantic proximity Read ↗

Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin.Semantic proximity Read ↗

High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation.Semantic proximity Read ↗

CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agentsSemantic proximity Read ↗

Differences in CD33 Intensity Between Various Myeloid NeoplasmsSemantic proximity Read ↗

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cellsSemantic proximity Read ↗

Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.